Zobrazeno 1 - 10
of 552
pro vyhledávání: '"Sanjay K, Srivastava"'
Autor:
Amy Kwan, Faith Howard, Natalie Winder, Emer Atkinson, Ameera Jailani, Priya B. Patel, Richard Allen, Penelope D. Ottewell, Gary C. Shaw, Joe Conner, Caroline Wilson, Sanjay K. Srivastava, Sarah J. Danson, Claire Lewis, Janet E. Brown, Munitta Muthana
Publikováno v:
Future Pharmacology, Vol 2, Iss 4, Pp 444-459 (2022)
Oncolytic viruses (OV) promote anti-tumour responses through the initiation of immunogenic cancer cell death which activates the host’s systemic anti-tumour immunity. We have previously shown that intravenously administered HSV1716 is an effective
Externí odkaz:
https://doaj.org/article/3b4d26e88bfb46238c249a242f2891a1
Publikováno v:
Molecular Therapy: Oncolytics, Vol 19, Iss , Pp 19-32 (2020)
Despite major advances in cancer treatment, pancreatic cancer is still incurable and the treatment outcomes are limited. The aggressive and therapy-resistant nature of pancreatic cancer warrants the need for novel treatment options for pancreatic can
Externí odkaz:
https://doaj.org/article/e9929c6e37a04d749550bbf99599f9c0
Publikováno v:
Plasmonics. 18:701-710
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d55215c32cf6320b66c6cb5c5d4526bb
https://doi.org/10.1007/s11468-023-01796-y
https://doi.org/10.1007/s11468-023-01796-y
Publikováno v:
Materials Today: Proceedings. 82:375-380
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::629c71db63dd92add661ea138dd249f8
https://doi.org/10.1016/j.matpr.2023.03.114
https://doi.org/10.1016/j.matpr.2023.03.114
Autor:
Urvashi Punia, Ruchi K. Sharma, Avritti Srivastava, Deepak Sharma, Premshila Kumari, Anjali Saini, J.S. Tawale, Prathap Pathi, Sanjay K. Srivastava
Publikováno v:
Materials Today: Proceedings. 82:192-197
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61fdcf704554843b4b7fba0036abf645
https://doi.org/10.1016/j.matpr.2022.12.231
https://doi.org/10.1016/j.matpr.2022.12.231
Publikováno v:
Materials Today: Proceedings. 82:158-162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3250d83bdc865aaf555ad9e7d812cc29
https://doi.org/10.1016/j.matpr.2022.12.114
https://doi.org/10.1016/j.matpr.2022.12.114
Publikováno v:
Seminars in Cancer Biology. 86:491-498
Immune check point inhibitors (ICIs) have marked their existence in the field of cancer immunotherapy. Their existence dates to 2011 when the first anti-cytotoxic T lymphocyte-associated protein 4 (CTLA-4) got its FDA approval for the management of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62277f044b0e34f8be8540b3022bf6d7
https://doi.org/10.1016/j.semcancer.2022.03.020
https://doi.org/10.1016/j.semcancer.2022.03.020
Publikováno v:
Silicon. 15:2099-2112
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a936ec401c5be5099533e954235a4d0f
https://doi.org/10.1007/s12633-022-02163-y
https://doi.org/10.1007/s12633-022-02163-y
Publikováno v:
Silicon. 15:1211-1220
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ba1bb950ee88a7da51c9c39422302c5
https://doi.org/10.1007/s12633-022-02100-z
https://doi.org/10.1007/s12633-022-02100-z
Autor:
Nehal Gupta, Sanjay K. Srivastava
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 521 (2021)
Triple-negative breast cancer (TNBC) is considered to be the most aggressive and malignant neoplasm and is highly metastatic in nature. In the current study, we investigated the anti-metastatic potential of atovaquone, a protozoal drug prescribed for
Externí odkaz:
https://doaj.org/article/07199edebc5d429b9f4a5ffff04d6e1c